Results
Supriya Lifescience Q2 PAT Declines 42% YoY
Supriya Lifescience reported Q2 FY27 unaudited results with revenue up 3.2% YoY to ₹2,063.0 Mn but PAT declined 42.0% to ₹292.5 Mn due to margin compression.
EBITDA margin contracted 1,435 bps YoY to
